NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125C909. A total of 5 filers reported holding NEUROCRINE BIOSCIENCES INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,183,962 | -80.1% | 8,600 | -80.0% | 0.01% | -78.3% |
Q1 2024 | $5,944,352 | +102.3% | 43,100 | +93.3% | 0.02% | +187.5% |
Q4 2023 | $2,938,248 | -27.2% | 22,300 | -37.9% | 0.01% | -42.9% |
Q3 2023 | $4,038,750 | +36.8% | 35,900 | +14.7% | 0.01% | +55.6% |
Q2 2023 | $2,951,590 | +3.0% | 31,300 | +10.6% | 0.01% | -10.0% |
Q1 2023 | $2,864,526 | -75.9% | 28,300 | -71.6% | 0.01% | -64.3% |
Q4 2022 | $11,908,168 | +416.6% | 99,700 | +359.4% | 0.03% | +460.0% |
Q3 2022 | $2,305,000 | -35.9% | 21,700 | -41.2% | 0.01% | -16.7% |
Q2 2022 | $3,597,000 | +31.4% | 36,900 | +26.4% | 0.01% | +100.0% |
Q1 2022 | $2,738,000 | +12.8% | 29,200 | +2.5% | 0.00% | +50.0% |
Q4 2021 | $2,427,000 | +116.3% | 28,500 | +143.6% | 0.00% | +100.0% |
Q3 2021 | $1,122,000 | -62.9% | 11,700 | -62.4% | 0.00% | -75.0% |
Q2 2021 | $3,027,000 | -38.5% | 31,100 | -38.5% | 0.00% | -42.9% |
Q1 2021 | $4,921,000 | +64.0% | 50,600 | +61.7% | 0.01% | +40.0% |
Q4 2020 | $3,000,000 | +124.4% | 31,300 | +125.2% | 0.01% | +25.0% |
Q3 2020 | $1,337,000 | +115.0% | 13,900 | +172.5% | 0.00% | +33.3% |
Q2 2020 | $622,000 | -61.4% | 5,100 | -72.6% | 0.00% | -76.9% |
Q1 2020 | $1,610,000 | -60.9% | 18,600 | -51.4% | 0.01% | -53.6% |
Q4 2019 | $4,117,000 | +552.5% | 38,300 | +447.1% | 0.03% | +460.0% |
Q3 2019 | $631,000 | +96.6% | 7,000 | +84.2% | 0.01% | +66.7% |
Q2 2019 | $321,000 | -57.7% | 3,800 | -55.8% | 0.00% | -62.5% |
Q1 2019 | $758,000 | -15.1% | 8,600 | -31.2% | 0.01% | 0.0% |
Q4 2018 | $893,000 | +503.4% | 12,500 | +941.7% | 0.01% | +700.0% |
Q3 2018 | $148,000 | -97.6% | 1,200 | -98.1% | 0.00% | -98.1% |
Q2 2018 | $6,140,000 | +161.6% | 62,500 | +120.8% | 0.05% | +120.8% |
Q1 2018 | $2,347,000 | +51.2% | 28,300 | +41.5% | 0.02% | +118.2% |
Q4 2017 | $1,552,000 | +1997.3% | 20,000 | +1566.7% | 0.01% | +1000.0% |
Q3 2017 | $74,000 | -95.1% | 1,200 | -96.4% | 0.00% | -93.8% |
Q2 2017 | $1,513,000 | +56.0% | 32,900 | +46.9% | 0.02% | +45.5% |
Q1 2017 | $970,000 | +31.3% | 22,400 | +17.3% | 0.01% | +57.1% |
Q4 2016 | $739,000 | -89.4% | 19,100 | -86.1% | 0.01% | -90.7% |
Q3 2016 | $6,943,000 | -6.0% | 137,100 | -15.6% | 0.08% | -13.8% |
Q2 2016 | $7,386,000 | +528.6% | 162,500 | +447.1% | 0.09% | +411.8% |
Q1 2016 | $1,175,000 | -70.5% | 29,700 | -57.8% | 0.02% | -63.8% |
Q4 2015 | $3,977,000 | +19.9% | 70,300 | -15.7% | 0.05% | +2.2% |
Q3 2015 | $3,318,000 | +20.0% | 83,400 | +44.0% | 0.05% | +17.9% |
Q2 2015 | $2,765,000 | +1.1% | 57,900 | -16.0% | 0.04% | -9.3% |
Q1 2015 | $2,736,000 | +24.6% | 68,900 | -29.9% | 0.04% | +30.3% |
Q4 2014 | $2,196,000 | +219.2% | 98,300 | +123.9% | 0.03% | +200.0% |
Q3 2014 | $688,000 | -43.7% | 43,900 | -46.7% | 0.01% | -42.1% |
Q2 2014 | $1,221,000 | +102.8% | 82,300 | +120.1% | 0.02% | +90.0% |
Q1 2014 | $602,000 | +82.4% | 37,400 | +5.9% | 0.01% | +100.0% |
Q4 2013 | $330,000 | -44.0% | 35,300 | -32.1% | 0.01% | -54.5% |
Q3 2013 | $589,000 | -35.9% | 52,000 | -24.3% | 0.01% | -52.2% |
Q2 2013 | $919,000 | – | 68,700 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PFM Health Sciences, LP | 261,500 | $25,080,000 | 0.74% |
SIMPLEX TRADING, LLC | 37,000 | $3,606,000 | 0.00% |
GROUP ONE TRADING, L.P. | 11,700 | $1,122,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |